First patient in UK given ‘vaccine’ for cancer in pioneering clinical research trial

Ground-breaking treatment at The Clatterbridge Cancer Centre aims to stop cancer returning

A Merseyside man has become the first in the UK to receive a ‘vaccine’ that is hoped will stop his recurring head and neck cancer from returning – in a clinical research trial which may help bring further ground-breaking treatments for the disease.

The clinical research team at The Clatterbridge Cancer Centre has given patient Graham Booth an injection of a therapy tailor-made to his personal DNA and designed to help his own immune system ward off cancer permanently.

link